These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6226378)

  • 41. Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor)Cl]+.
    Hollis LS; Amundsen AR; Stern EW
    J Med Chem; 1989 Jan; 32(1):128-36. PubMed ID: 2909724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relative mutagenic and prophage-inducing effects of mono- and di-alkyl nitrosoureas.
    Lijinsky W; Elespuru RK; Andrews AW
    Mutat Res; 1987 Jun; 178(2):157-65. PubMed ID: 2953969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of the microscreen phage-induction assay to assess the genotoxicity of 14 hazardous industrial wastes.
    Houk VS; DeMarini DM
    Environ Mol Mutagen; 1988; 11(1):13-29. PubMed ID: 2962869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.
    Schmittgen TD; Ju JF; Danenberg KD; Danenberg PV
    Int J Oncol; 2003 Sep; 23(3):785-9. PubMed ID: 12888918
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs.
    Yarema KJ; Wilson JM; Lippard SJ; Essigmann JM
    J Mol Biol; 1994 Mar; 236(4):1034-48. PubMed ID: 8120885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of prophage lambda by chlorinated pesticides.
    Houk VS; DeMarini DM
    Mutat Res; 1987 Aug; 182(4):193-201. PubMed ID: 2956515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride.
    Cafaggi S; Esposito M; Parodi B; Vannozzi MO; Viale M; Pellecchia C; Fulco RA; Merlo F; Zicca A; Cadoni A
    Anticancer Res; 1992; 12(6B):2285-92. PubMed ID: 1295476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Acute and subacute toxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in laboratory rodents].
    Härtl A; Güttner J; Horn U; Jelinek F; Stöckel U; Schröer HP; Hoffmann H
    Arch Geschwulstforsch; 1989; 59(4):239-44. PubMed ID: 2640563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Development of antitumor platinum complexes].
    Kidani Y
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2442-52. PubMed ID: 6360050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prophage induction and reactivation of phage lambda as affected by dioxidine].
    Bakaĭ TS; Fonshteĭn LM
    Tsitol Genet; 1982; 16(6):38-40. PubMed ID: 6218669
    [No Abstract]   [Full Text] [Related]  

  • 52. The genetic toxicology of metal compounds: I. Induction of lambda prophage in E coli WP2s(lambda).
    Rossman TG; Molina M; Meyer LW
    Environ Mutagen; 1984; 6(1):59-69. PubMed ID: 6229401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.
    Heiger-Bernays WJ; Essigmann JM; Lippard SJ
    Biochemistry; 1990 Sep; 29(36):8461-6. PubMed ID: 2174701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on mutagenesis and repair induced by platinum analogs.
    Fram RJ; Cusick PS; Marinus MG
    Mutat Res; 1986 Jan; 173(1):13-8. PubMed ID: 3510378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
    Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutagenic activities of simple nitrofuran derivatives. I. Comparison of related compounds in the phage inductest, chloroplast-bleaching and bacterial-repair and mutagenicity tests.
    Soska J; Koukalová B; Ebringer L
    Mutat Res; 1981 Mar; 81(1):21-6. PubMed ID: 6454838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between the toxicity of platinum drugs to L1210 leukaemia cells and their mutagenic properties.
    Lecointe P; Macquet JP; Butour JL
    Biochem Biophys Res Commun; 1979 Sep; 90(1):209-13. PubMed ID: 159050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.